2-[5-[[7-[3-[3-[2-[2-[2-[[4-[2-[2-[2-[[4-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methyl-[[3-(3-carboxypropanoyloxymethoxycarbonyl)-4-[(2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl)oxy]phenyl]methoxycarbonyl]amino]benzoyl]amino]-4-carboxybutanoyl]amino]ethoxy]ethoxy]ethylamino]-4-oxo-2-[[2-[2-[2-[2-(2-oxopropoxy)ethoxy]ethoxy]ethoxy]acetyl]amino]butanoyl]amino]ethoxy]ethoxy]ethoxy]propanoylamino]propyl]-1,4-dioxonaphthalen-2-yl]methoxycarbonyl-[(3-methyl-1-oxo-2H-benzo[f]quinazolin-9-yl)methyl]amino]-1-hydroxyisoindol-2-yl]pentanedioic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-[5-[[7-[3-[3-[2-[2-[2-[[4-[2-[2-[2-[[4-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methyl-[[3-(3-carboxypropanoyloxymethoxycarbonyl)-4-[(2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl)oxy]phenyl]methoxycarbonyl]amino]benzoyl]amino]-4-carboxybutanoyl]amino]ethoxy]ethoxy]ethylamino]-4-oxo-2-[[2-[2-[2-[2-(2-oxopropoxy)ethoxy]ethoxy]ethoxy]acetyl]amino]butanoyl]amino]ethoxy]ethoxy]ethoxy]propanoylamino]propyl]-1,4-dioxonaphthalen-2-yl]methoxycarbonyl-[(3-methyl-1-oxo-2H-benzo[f]quinazolin-9-yl)methyl]amino]-1-hydroxyisoindol-2-yl]pentanedioic acid
• 英文别名: 2-[5-[[7-[3-[3-[2-[2-[2-[[4-[2-[2-[2-[[4-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methyl-[[3-(3-carboxypropanoyloxymethoxycarbonyl)-4-[(2-oxo-1,3,2λ5-dioxaphosphinan-2-yl)oxy]phenyl]methoxycarbonyl]amino]benzoyl]amino]-4-carboxybutanoyl]amino]ethoxy]ethoxy]ethylamino]-4-oxo-2-[[2-[2-[2-[2-(2-oxopropoxy)ethoxy]ethoxy]ethoxy]acetyl]amino]butanoyl]amino]ethoxy]ethoxy]ethoxy]propanoylamino]propyl]-1,4-dioxonaphthalen-2-yl]methoxycarbonyl-[(3-methyl-1-oxo-2H-benzo[f]quinazolin-9-yl)methyl]amino]-1-hydroxyisoindol-2-yl]pentanedioic acid
• 化学式: C₁₀₈H₁₂₅N₁₆O₄₁P
• 分子量: 2334.2
• InChiKey: NTTAIYXATNTTKD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  166
• 可旋转键数：
  75
• 环数：
  12.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  774
• 氢给体数：
  14
• 氢受体数：
  45